276 related articles for article (PubMed ID: 37460222)
1. Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance.
Li X; Jusko WJ
Drug Metab Dispos; 2023 Oct; 51(10):1403-1418. PubMed ID: 37460222
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Pharmacokinetic Mysteries of the Liver: Application of Series Compartment Models of Hepatic Elimination.
Li X; Jusko WJ
Drug Metab Dispos; 2023 May; 51(5):618-628. PubMed ID: 36732075
[TBL] [Abstract][Full Text] [Related]
3.
Li X; Jusko WJ
Drug Metab Dispos; 2022 Oct; ():. PubMed ID: 36195337
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
Peters SA
Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
[TBL] [Abstract][Full Text] [Related]
5. Applications of minimal physiologically-based pharmacokinetic models.
Cao Y; Jusko WJ
J Pharmacokinet Pharmacodyn; 2012 Dec; 39(6):711-23. PubMed ID: 23179857
[TBL] [Abstract][Full Text] [Related]
6. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
Peters SA
Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
[TBL] [Abstract][Full Text] [Related]
7. Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species.
Jeong YS; Jusko WJ
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34200427
[TBL] [Abstract][Full Text] [Related]
8. A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter f
Jeong YS; Jusko WJ
J Pharm Sci; 2024 Jan; 113(1):95-117. PubMed ID: 37279835
[TBL] [Abstract][Full Text] [Related]
9. Physiologically Based Pharmacokinetic Modeling: The Reversible Metabolism and Tissue-Specific Partitioning of Methylprednisolone and Methylprednisone in Rats.
Yu R; Jusko WJ
Drug Metab Dispos; 2024 Jun; 52(7):662-672. PubMed ID: 38653502
[TBL] [Abstract][Full Text] [Related]
10. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
Poulin P; Theil FP
J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
[TBL] [Abstract][Full Text] [Related]
12. Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.
Pang KS; Durk MR
J Pharmacokinet Pharmacodyn; 2010 Dec; 37(6):591-615. PubMed ID: 21153869
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
Poirier A; Funk C; Scherrmann JM; Lavé T
Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
[TBL] [Abstract][Full Text] [Related]
14. Survey of monoclonal antibody disposition in man utilizing a minimal physiologically-based pharmacokinetic model.
Cao Y; Jusko WJ
J Pharmacokinet Pharmacodyn; 2014 Dec; 41(6):571-80. PubMed ID: 25146360
[TBL] [Abstract][Full Text] [Related]
15. Consideration of Fractional Distribution Parameter f
Jeong YS; Jusko WJ
Pharm Res; 2022 Mar; 39(3):463-479. PubMed ID: 35288804
[TBL] [Abstract][Full Text] [Related]
16. Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling.
Thompson MD; Beard DA; Wu F
J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):313-27. PubMed ID: 22639356
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Kochak-Benet Equation for Hepatic Clearance for the Parallel-Tube Model: Relevance of Classic Clearance Concepts in PK and PBPK.
Jusko WJ; Li X
AAPS J; 2021 Dec; 24(1):5. PubMed ID: 34853928
[TBL] [Abstract][Full Text] [Related]
18. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
[TBL] [Abstract][Full Text] [Related]
19. Predicting In Vivo Target Occupancy (TO) Profiles via Physiologically Based Pharmacokinetic-TO Modeling of Warfarin Pharmacokinetics in Blood: Importance of Low Dose Data and Prediction of Stereoselective Target Interactions.
Lee W; Kim MS; Kim J; Aoki Y; Sugiyama Y
Drug Metab Dispos; 2023 Sep; 51(9):1145-1156. PubMed ID: 36914276
[TBL] [Abstract][Full Text] [Related]
20. The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution-A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling.
Gaohua L; Zhang M; Sychterz C; Chang M; Schmidt BJ
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
